Table 2. Univariate and multivariate analysis regarding overall survival in patients with ccRCC.

Variables	Univariate				Multivariate
	OR	95% CI	P		OR	95% CI	P
Age (y)
<65 vs. >65	3.438	1.085–10.894	0.036		2.871	0.817–10.082	0.100
Sex
Male vs. female	1.352	0.427–4.277	0.608
Hypertension
Yes vs. no	0.806	0.259–2.522	0.709
Diabetes mellitus
Yes vs. no	25.613	0.020–32,358.570	0.373
Location
Left vs. right	3.086	0.829–11.487	0.093
Surgical approach
NSS vs. RN	3.172	0.854–11.782	0.085
BMI (kg/m2)
<25 vs. >25	0.315	0.069–1.445	0.137
NLR
<3 vs. >3	1.936	0.621–6.032	0.255
PLR
<132 vs. >132	1.018	0.321–3.231	0.975
CD3+ T cell (cells/μL)
<770 vs. >770	0.302	0.096–0.951	0.041		0.295	0.091–0.956	0.042
CD4+ T cell (cells/μL)
<500 vs. >500	0.704	0.221–2.241	0.553
CD8+ T cell (cells/μL)
<238 vs. >238	0.475	0.148–1.523	0.211
CD4+/CD8+ ratio
<1.0 vs. >1.0	0.185	0.055–0.626	0.007		0.244	0.065–0.920	0.037
MAP score
0–2 vs. 3–5	1.622	0.511–5.147	0.412
RENAL score
4–6 vs. 7–12	4.475	0.576–34.770	0.152
Tumor size (cm)
<5 vs. >5	4.431	0.965–20.353	0.056
T stage
T1–2 vs. T3–4	1.779	0.475–6.665	0.392
Fuhrman grade
1–2 vs. 3–4	1.259	0.403–3.928	0.692

BMI, body mass index; NLR, neutrophil to lymphocyte ratio; PLR, platelet to lymphocyte ratio; MAP, Mayo adhesive probability.